Latest News
- The Rare Cancer EU Access Index Survey: We need your input from the Sarcoma-Community...
- “My GIST Companion” - app to support adherence in GIST patients
- Genetic Risk Factor for Chordoma Identified
- EMA will review a marketing authorization application for Masitinib in the treatment of Imatinib resistant GIST
- EMA will review a marketing authorization application for Masitinib in the treatment of Imatinib resistant GIST
Latest Events
- 29.05.2013 - 31.05.2013 26th EMSOS Annual ...
- 31.05.2013 - 04.06.2013 ASCO Annual Meetin...
- 30.10.2013 - 05.11.2013 CTOS Annual Meetin...
Our visitors are from ...
Top 5:
70943 visits from 136 countries
 | 8% | Ukraine (5765) |
 | 5% | Germany (3813) |
 | 4% | Netherlands (2863) |
 | 4% | Russian Federation (2856) |
 | 3% | United Kingdom (2470) |
|
|
